Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 10 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
Systems and methods for identifying malicious domains using internet-wide DNS lookup patterns
Platform for generating electricity from flowing fluid using generally prolate turbine
Optoelectronic component and method for producing an optoelectronic component
Visual universal decryption apparatus and methods
Method for delivering a volatile material
Power management implementation in an optical link
SRB enhancement on HS-DSCH during cell change
  Randomly Featured Patents
Zero voltage switching power converters
Level with magnetic device
Hanging necktie holder
Integrated circuit using a dual poly process
Method and apparatus for selectively controlling interrupt latency in a data processing system
Impregnation type cathode for a cathodic ray tube
Transducer suspension system
Light-modulating material with transmissivity changing in electrified state and vehicle using the same
Chryanthemum plant named `Yobonnie`
Inkjet recording apparatus